China and US agree to extend trade tariff truce, says Li
Align Technology , Inc. (NASDAQ:ALGN) stock has reached a 52-week low, dipping to $196.04, as investors navigate through a tumultuous market environment. With a market capitalization of $14.65 billion and a beta of 1.67, the stock’s volatility has been notable. InvestingPro analysis suggests the stock may be undervalued at current levels. The company, known for its innovative dental products, including the Invisalign system, has experienced significant volatility over the past year. This latest price level reflects a stark contrast to the stock’s performance over the year, with Align Technology witnessing a 1-year decline of -35%. Despite challenges, the company maintains a robust gross margin of 70% and management has been actively buying back shares. The decline to this 52-week low underscores the challenges faced by the dental device sector amidst changing consumer spending habits and competitive pressures. Investors are closely monitoring the company’s strategic moves to revitalize growth and improve shareholder value in the coming quarters. For deeper insights into ALGN’s valuation and growth prospects, including 8 additional exclusive ProTips, visit InvestingPro.
In other recent news, Align Technology reported fourth-quarter earnings that slightly missed analyst estimates, posting adjusted earnings per share of $2.44 compared to the expected $2.46. The company’s revenue for the quarter was $995.2 million, just shy of the anticipated $1 billion. Align Technology also provided guidance for the first quarter, forecasting revenue between $965 million to $985 million, which is below Wall Street’s projection of $1.03 billion. This outlook was attributed to unfavorable foreign exchange rates and lower capital equipment sales.
In terms of analyst actions, Wells Fargo (NYSE:WFC) initiated coverage of Align Technology with an Overweight rating and a price target of $255.00, highlighting the company’s strong market position and brand recognition. Conversely, Piper Sandler adjusted its price target from $275.00 to $270.00 while maintaining an Overweight rating, following Align’s earnings report. Piper Sandler noted that the company’s future guidance reflects a realistic view of the current economic environment.
Align Technology’s management acknowledged the challenges posed by the economy but remained optimistic about growth opportunities, especially in select international markets. The company reported full-year 2024 revenue of $4.0 billion, a 3.5% increase from the previous year. Looking ahead to 2025, Align anticipates "low single digits" revenue growth, with Clear Aligner volume growth in the "mid-single digits."
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.